Ferrosa – ferro liposomiale e vitamina D3 vegana da lichene: un approccio nutrizionale integrato per supportare stato del ferro, metabolismo energetico e fisiologia della vitamina D

Ferrosa – liposomal iron and vegan lichen-derived vitamin D3: an integrated nutritional approach to support iron status, energy metabolism, and vitamin D physiology

Vitamin D is an essential micronutrient for maintaining the body's physiological balance. Its best-known function is to support the normal absorption and use of calcium and phosphorus, contributing to the maintenance of normal bones and teeth and normal muscle function. However, it is now known that vitamin D exerts broader activities through the vitamin D receptor (VDR), which is present in numerous tissues, including those involved in regulating the immune response.

Vitamin D can be synthesized by the body through exposure to UVB rays or obtained through diet and supplementation. Natural food sources are limited and predominantly animal-based, while factors such as advanced age, reduced sun exposure, increased nutritional requirements, or specific dietary habits can make it more difficult to achieve adequate intake.

Because vitamin D is a fat-soluble vitamin, it is physiologically absorbed in the presence of dietary lipids and requires subsequent metabolic transformations to become biologically active.

In this context, Ferrosa offers a formulation that combines liposomal iron with selected micronutrients, including vegan vitamin D3 obtained from lichen, a non-animal source of cholecalciferol, along with other nutrients involved in energy metabolism and the maintenance of normal physiological functions.

 The formulation combines liposomal technology for iron and vitamin C with selected vitamins and trace elements to support nutritional needs and gastrointestinal tolerability.

PRODUCT_ITEM

Dosage

It is recommended to take 1 capsule daily, at any time of day.

If necessary, the dosage may be adjusted under medical supervision.

Functional composition per daily dose (1 capsule)

Iron: 20 mg (143% NRV)
Vitamin C: 80 mg (100% NRV)
Vitamin B12: 25 μg (1000% NRV)
Zinc: 2.5 mg (25% NRV)
Vitamin E: 6 mg (50% NRV)
Vitamin K2: 22 μg (29% NRV)
Selenium: 55 μg (100% NRV)
Lichen-derived vitamin D3: 20 μg (400% NRV)
Vitamin A: 400 μg (50% NRV)
Vitamin B6: 1.4 mg (100% NRV)
Vitamin B2: 1.4 mg (100% NRV)
Vitamin B1: 1.1 mg (100% NRV)
Folic acid: 200 μg (100% NRV)

Rationale for the formulation

1. Liposomal iron and nutritional bioavailability

Ferrosa uses micronized liposomal iron pyrophosphate.

Liposomal technology was developed to protect iron from direct contact with the gastric environment and to promote better intestinal tolerability compared to some traditional formulations. The technical data sheet highlights the rationale for protecting the nutrient and supporting absorption.

Iron contributes:

  • to the normal formation of red blood cells and hemoglobin;
  • to normal energy metabolism;
  • to the reduction of tiredness and fatigue;
  • to normal cognitive function;
  • to the normal functioning of the immune system.

2. Vegan vitamin D3: a distinctive feature of the formulation

One of the aspects that distinguishes Ferrosa is the presence of lichen-derived vitamin D3.

As highlighted in the previous section, many vitamin D3 formulations historically derive from animal-based lanolin or do not immediately state the source of the raw material.

Ferrosa, on the other hand, uses vegan lichen-derived vitamin D3, listed as a dedicated ingredient in the product's technical documentation.

Physiologically, cholecalciferol obtained from lichen follows the same metabolic pathways as conventional vitamin D3.

Vitamin D contributes:

  • to the normal functioning of the immune system;
  • to the normal absorption and use of calcium and phosphorus;
  • to the maintenance of normal bones;
  • to the maintenance of normal muscle function.

3. Liposomal vitamin C as a nutritional cofactor

Vitamin C is one of the nutrients most extensively studied in iron physiology.

At a biological level, it helps maintain iron in its ferrous state and promotes the absorption of non-heme dietary iron.

The combination with iron is one of the most well-established nutritional rationales in the formulation of iron supplements.

4. Synergistic micronutrients: vitamin B12, folate, zinc, and selenium

The presence of vitamin B12 and folic acid places the product within a nutritional framework focused on cellular formation and metabolism.

Zinc and selenium, on the other hand, participate in numerous enzymatic reactions and the maintenance of immune function.

Vitamin E and vitamin K2 complete the antioxidant and nutritional profile of the formulation.

Who might benefit from the nutritional rationale of Ferrosa

The product may be suitable for those with increased iron requirements, reduced dietary intake, or those who wish to supplement with a formulation that also includes vegan vitamin D3 and associated micronutrients.

IMPORTANT NOTE

The information provided in the product sheets on this website is for informational and educational purposes only and does not constitute medical advice. The published content is not intended to replace a relationship with a doctor or any medical advice, diagnosis, or prescription. The information provided describes the ingredients and characteristics of the food supplements, which are designed to support the body's balance and well-being as part of a healthy lifestyle. Food supplements are not medicines and should not be used to prevent, diagnose, treat, or alleviate diseases or medical conditions.

Bibliography

Holick MF. Vitamin D Deficiency. New England Journal of Medicine.

Cashman KD et al. Vitamin D deficiency in Europe.

Tripkovic L et al. Comparison of vitamin D2 and vitamin D3 supplementation.

EFSA Panel on Nutrition. Dietary Reference Values for Vitamin D.

Camaschella C. Iron deficiency.

Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation.

Hurrell R, Egli I. Iron bioavailability and dietary factors.

LARN – Nutrient and Energy Reference Intake Levels for the Italian population.

Regulation (EU) No 1169/2011.

Directive 2002/46/EC.